Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 8/20 | 0.37 |
| ▸ | AURKA | O14965 | 5/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3048894 | 0.85 | AKR1C3 (0.45) | AKR1C3KDRAURKACDK1CHEK1 | |
| SCHEMBL3047573 | 0.82 | KDR (0.46) | NPC1KDRAURKACDK1CHEK1 | |
| SCHEMBL3047349 | 0.82 | AKR1C3 (0.47) | AKR1C3KDRAURKACDK1CHEK1 | |
| SCHEMBL3047974 | 0.81 | KDR (0.44) | AKR1C3KDRAURKACDK1CHEK1 | |
| SCHEMBL3049984 | 0.80 | KDR (0.43) | AKR1C3KDRAURKACDK1CHEK1 | |
| SCHEMBL3047646 | 0.80 | KDR (0.45) | KDRAURKACDK1CHEK1 | |
| SCHEMBL3051432 | 0.79 | KDR (0.46) | AKR1C3KDRAURKACDK1POLB | |
| SCHEMBL3033406 | 0.79 | KDR (0.45) | KDRAURKACDK1 | |
| Hydrochloric Acid SCHEMBL3047329 | 0.78 | KDR (0.52) | KDRAURKACDK1CHEK1 | |
| Hydrochloric Acid SCHEMBL3046318 | 0.77 | AURKA (0.38) | KDRAURKACDK1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745641-B2 | Nitrogen-containing heterocyclic compound | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-06-29 | — | — | US | disclosed |
| US-20090054407-A1 | Nitrogen-containing heterocyclic compound | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1880993-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054407-A1 | Nitrogen-containing heterocyclic compound | NR4A1, NR5A2, PRMT8 | AKR1C3 1507/4885HCRTR1 167/4885NPC1 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.